Healthcare -
Drug Manufacturers - General - NYSE - DK
$ 90.65
1.6 %
$ 399 B
Market Cap
28.51
P/E
NVO - STOCK-BASED COMPENSATION
Stock-based Compensation NVO - Novo Nordisk A/S
2.29 B
LAST VALUE
21.96%
2 YEAR CAGR
44.53%
5 YEAR CAGR
19.96%
10 YEAR CAGR